Search research articles
Contact Us
Filters
Showing results (111-120 of 170) with videos related to
Page
of 17
Sort By:
Scientific Reports
|
August 24, 2016
Pregnane X Receptor Regulates Pathogen-Induced Inflammation and Host Defense against an Intracellular Bacterial Infection through Toll-like Receptor 4
Zhijuan Qiu, Jorge L Cervantes, Basak B Cicek, et al.
International Journal of Molecular Sciences
|
April 15, 2020
Gut Microbial Catabolites of Tryptophan Are Ligands and Agonists of the Aryl Hydrocarbon Receptor: A Detailed Characterization
Barbora Vyhlídalová, Kristýna Krasulová, Petra Pečinková, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
October 29, 2022
The Pregnane X Receptor and Indole-3-Propionic Acid Shape the Intestinal Mesenchyme to Restrain Inflammation and Fibrosis
Kyle L Flannigan, Kristoff M Nieves, Holly E Szczepanski, et al.
Bioorganic Chemistry
|
February 14, 2025
Decoding structural determinants of aryl hydrocarbon receptor antagonism by monoterpenoids
Iveta Zůvalová, Barbora Vyhlídalová, Karolína Ondrová, et al.
Investigational New Drugs
|
January 2, 2007
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers
Sanjay Goel, Kavita Desai, Sirisha Karri, et al.
American Journal of Clinical Oncology
|
October 24, 2002
Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies
Sanjay Goel, Minaxi Jhawer, Lakshmi Rajdev, et al.
Pediatric Research
|
January 24, 2018
Targeting the PXR-TLR4 signaling pathway to reduce intestinal inflammation in an experimental model of necrotizing enterocolitis
Kezhen Huang, Subhajit Mukherjee, Vera DesMarais, et al.
American Journal of Clinical Oncology
|
December 4, 2004
A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma
Cathy Eng, Ramesh K Ramanathan, Ramesh K Ramathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2004
Phase I clinical and pharmacokinetic study of BMS-247550, a novel derivative of epothilone B, in solid tumors
Sridhar Mani, Hayley McDaid, Anne Hamilton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
A phase 1 open-label, accelerated dose-escalation study of the hypoxia-activated prodrug AQ4N in patients with advanced malignancies
Kyriakos P Papadopoulos, Sanjay Goel, Murali Beeram, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 170) with videos related to
Sort By:
Page
of 17
Scientific Reports
|
August 24, 2016
Pregnane X Receptor Regulates Pathogen-Induced Inflammation and Host Defense against an Intracellular Bacterial Infection through Toll-like Receptor 4
Zhijuan Qiu, Jorge L Cervantes, Basak B Cicek, et al.
International Journal of Molecular Sciences
|
April 15, 2020
Gut Microbial Catabolites of Tryptophan Are Ligands and Agonists of the Aryl Hydrocarbon Receptor: A Detailed Characterization
Barbora Vyhlídalová, Kristýna Krasulová, Petra Pečinková, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
October 29, 2022
The Pregnane X Receptor and Indole-3-Propionic Acid Shape the Intestinal Mesenchyme to Restrain Inflammation and Fibrosis
Kyle L Flannigan, Kristoff M Nieves, Holly E Szczepanski, et al.
Bioorganic Chemistry
|
February 14, 2025
Decoding structural determinants of aryl hydrocarbon receptor antagonism by monoterpenoids
Iveta Zůvalová, Barbora Vyhlídalová, Karolína Ondrová, et al.
Investigational New Drugs
|
January 2, 2007
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers
Sanjay Goel, Kavita Desai, Sirisha Karri, et al.
American Journal of Clinical Oncology
|
October 24, 2002
Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies
Sanjay Goel, Minaxi Jhawer, Lakshmi Rajdev, et al.
Pediatric Research
|
January 24, 2018
Targeting the PXR-TLR4 signaling pathway to reduce intestinal inflammation in an experimental model of necrotizing enterocolitis
Kezhen Huang, Subhajit Mukherjee, Vera DesMarais, et al.
American Journal of Clinical Oncology
|
December 4, 2004
A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma
Cathy Eng, Ramesh K Ramanathan, Ramesh K Ramathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2004
Phase I clinical and pharmacokinetic study of BMS-247550, a novel derivative of epothilone B, in solid tumors
Sridhar Mani, Hayley McDaid, Anne Hamilton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
A phase 1 open-label, accelerated dose-escalation study of the hypoxia-activated prodrug AQ4N in patients with advanced malignancies
Kyriakos P Papadopoulos, Sanjay Goel, Murali Beeram, et al.
Page
of 17